Cellyan Biotechnology Co. Ltd. HKPD

What this company does

Our business offering consists of two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, primarily conducted through our Hong Kong subsidiary, Joint Cross Border, which we refer to as the “Supply Chain Services” division and (ii) OTC pharmaceutical cross-border procurement and distribution, primarily conducted through our Hong Kong subsidiary, V-Alliance, which we refer to as the “Procurement and Distribution” division. As of the date of this Annual Report, our system has cataloged more than 6,000 SKUs, including around 6,000 HKDOH-enlisted OTC SKUs. As of March 31, 2026, we provided services to over 300 online merchants. As of March 31, 2026, 2025, 2024 we had a total of 11, 27, 19 full-time employees, all based in Hong Kong to support our business operations.

Written from the business description in Cellyan Biotechnology Co., Ltd's annual report to the U.S. Securities and Exchange Commission, filed 7 August 2026. Every sentence was checked against that document before publication.